FDA Approved: LEVETIRACETAM — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from BluePoint Laboratories under ANDA 078993. This approval relates to the generic anticonvulsant use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)